Preliminary imaging results with 18F-2-fluoro-2-deoxy-D-glucose

Area of Science:

• Nuclear medicine
• Neuroimaging
• Positron Emission Tomography (PET)

Background:

• Quantitative assessment of regional glucose metabolism is crucial for understanding brain function.
• 18F-2-fluoro-2-deoxy-D-glucose (2FDG) is a radiotracer used to measure glucose metabolism.
• Transverse section imaging offers detailed visualization of metabolic activity.

Purpose of the Study:

• To present preliminary results of transverse section imaging using 2FDG.
• To demonstrate the feasibility of quantitative glucose metabolism assessment with 2FDG.
• To report the distribution patterns of 2FDG in different subjects.

Main Methods:

• Utilized 18F-2-fluoro-2-deoxy-D-glucose (2FDG) produced at Brookhaven National Laboratory.
• Employed the PCII scanner at Massachusetts General Hospital for imaging.
• Acquired transverse section images to visualize 2FDG distribution.

Main Results:

• Successfully imaged 2FDG distribution in three distinct studies.
• Observed 2FDG distribution in a dog, a monkey, and the brain of a normal human patient.
• Preliminary data suggests the potential for quantitative metabolic analysis.

Conclusions:

• Transverse section imaging with 2FDG shows promise for quantitative glucose metabolism studies.
• The presented data supports the use of 2FDG in neuroimaging research.
• Further studies are warranted to fully establish the clinical utility of 2FDG PET imaging.